Medical diagnostics developer Drawbridge Health has secured capital from Kyoto University Innovation Capital thanks to a meeting at the GUV: Fusion conference.
Drawbridge Health, a US-based medical diagnostics spinout of industrial conglomerate General Electric (GE), received an undisclosed amount of funding yesterday from Kyoto University’s venturing arm Innovation Capital (KU-iCap).
KU-iCap invested through its fund, Innovation Kyoto 2016.
Drawbridge Health was founded 2015 as a spinout of GE Healthcare with the support of the corporate’s investment division, GE Ventures. Drawbridge is working on a blood-sampling device for medical diagnostics that is designed to be more reliable and convenient than conventional methods.
The company hopes its approach will improve the patient’s experience by reducing waiting times and the pain associated with drawing blood.
Following the investment, Drawbridge will work closely with Kyoto University researchers led by Nobuya Inagaki, chairman of the Department of Diabetes, Endocrinology and Nutrition, and Kaori Ikeda, an assistant professor in the university’s hospital system.
GE unveiled Drawbridge Health in November 2017, when TechCrunch reported the corporate expected to supply Drawbridge with funding, though further details have not been disclosed.
The latest deal was made possible through a meeting at the GUV: Fusion conference, Koji Murota, chief executive of KU-iCap, confirmed to Global University Venturing. Murota will also be a speaker at the GUV Summit on November 8 and 9 in Houston, Texas, tickets for which are available now.
